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Abstract
Background: Because residents of the southeastern United States experience disproportionally high rates of
cardiovascular disease (CVD), it is important to develop effective lifestyle interventions for this population.
Methods: The primary objective was to develop and evaluate a dietary, physical activity (PA) and weight
loss intervention for residents of the southeastern US. The intervention, given in eastern North Carolina, was
evaluated in a 2 year prospective cohort study with an embedded randomized controlled trial (RCT) of a
weight loss maintenance intervention. The intervention included: Phase I (months 1–6), individually-tailored
intervention promoting a Mediterranean-style dietary pattern and increased walking; Phase II (months 7–12),
option of a 16-week weight loss intervention for those with BMI ≥ 25 kg/m2 offered in 2 formats (16 weekly
group sessions or 5 group sessions and 10 phone calls) or a lifestyle maintenance intervention; and Phase III
(months 13–24), weight loss maintenance RCT for those losing ≥ 8 lb with all other participants receiving a
lifestyle maintenance intervention. Change in diet and PA behaviors, CVD risk factors, and weight were
assessed at 6, 12, and 24 month follow-up.
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Results: Baseline characteristics (N = 339) were: 260 (77 %) females, 219 (65 %) African Americans, mean age 56 years,
and mean body mass index 36 kg/m2. In Phase I, among 251 (74 %) that returned for 6 month follow-up, there were
substantial improvements in diet score (4.3 units [95 % CI 3.7 to 5.0]), walking (64 min/week [19 to 109]), and systolic
blood pressure (−6.4 mmHg [−8.7 to −4.1]) that were generally maintained through 24 month follow-up. In Phase II,
138 (57 group only, 81 group/phone) chose the weight loss intervention and at 12 months, weight change was: −3.
1 kg (−4.9 to −1.3) for group (N = 50) and −2.1 kg (−3.2 to −1.0) for group/phone combination (N = 75). In Phase III, 27
participants took part in the RCT. At 24 months, weight loss was −2.1 kg (−4.3 to 0.0) for group (N = 51) and −1.1 kg
(−2.7 to 0.4) for combination (N = 72). Outcomes for African American and whites were similar.
Conclusions: The intervention yielded substantial improvement in diet, PA, and blood pressure, but weight loss was
modest.
Trial registration: clinicaltrials.gov Identifier: NCT01433484
Keywords: Mediterranean diet, Dietary intervention, Lifestyle intervention, Weight loss intervention, Low-income
participants, Disparities, Cardiovascular disease, Prevention
Background
In the United States (US), large disparities in cardiovas-
cular disease (CVD) exist among subgroups defined by
race, ethnicity, socioeconomic status (SES), and geog-
raphy (with rates high in the Southeast, particularly in
the “stroke belt”) [1–6]. The reasons are complex and
include differences in genetic factors, access to and qual-
ity of care [7, 8], and lifestyle factors [5, 6]. Notably,
individuals of low SES and minority status, and more
generally, residents of the southeastern US, typically
consume less fruit and vegetables [9–12], engage in less
leisure-time physical activity (PA) [13, 14], and are more
likely to be obese [15] compared to higher SES, non-
minority, and non-southeastern counterparts. As diet
and PA behaviors are modifiable and, if sustained, are
associated with substantial reduction in CVD risk
[16, 17], improving diet and PA behaviors in high
risk groups affords an opportunity to substantially
reduce CVD disparities.
Dietary patterns that include frequent consumption of
high quality fats (polyunsaturated and monounsaturated
fats primarily from plant sources and fish) and carbohy-
drates (fruits, vegetables, and whole grains) are associ-
ated with large reductions in CVD risk [16, 18, 19]. In
the PREDIMED randomized trial [20], a Mediterranean
dietary pattern supplemented with nuts or olive oil re-
duced CVD risk by 30 % in the intervention groups.
While the Mediterranean dietary pattern has been well
studied in Europe [21–23] and in selected US popula-
tions [24–28], it has not been evaluated in high risk,
largely minority populations in the southeastern US.
Further, the Mediterranean dietary pattern holds promise
for weight loss interventions as it may be easier to main-
tain over time, especially compared to low fat diets [29].
Given the importance of dietary patterns in reducing
CVD risk [30], and the burden of CVD risk among
residents of the “stroke belt” in eastern North Carolina
[4], we developed and evaluated a culturally appropriate
lifestyle intervention for this population, with a major
focus on improving diet quality while also promoting PA
and weight loss. In this paper we report the interven-
tion’s effect on diet and PA behaviors, CVD risk factors,
and weight loss through 24 months of follow-up. Be-
cause a major focus of this research was to reduce
disparities in CVD risk, outcomes are also reported by
race, as African Americans are at increased risk for CVD
[3], but often have poorer outcomes compared to whites
in response to lifestyle and weight loss interventions
[31–34].
Methods
Study overview
Situated in eastern North Carolina, Lenoir County is
located in the “stroke belt,” [4] with elevated heart dis-
ease and stroke rates relative to other regions of North
Carolina [35] and national levels [36]. This study was
part of the Heart Healthy Lenoir (HHL) Project [37], a
collaborative research effort designed to reduce CVD
risk and disparities in risk in Lenoir County. This paper
reports on the lifestyle intervention study, one of 3
coordinated HHL studies which also included a study to
improve high blood pressure (BP) management at local
practices and a study examining associations between
genetic markers and change in CVD risk factors. Life-
style study participants were recruited from the commu-
nity and also included some participants who took part
in the HHL high BP study [38]. The study was designed
and conducted with input from a local Community
Advisory Committee (CAC) [37] with data collected
from September 20, 2011 to November 7, 2014 and ana-
lyzed in 2015 and 2016.
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The lifestyle study included 3 phases, as depicted in
Fig. 1. Phase I, lasting 6 months and given to all partici-
pants, focused on improving diet quality and increasing
PA. In Phase II, also 6 months in length, participants
with a body mass index (BMI) ≥ 25 kg/m2 were invited
to take part in a weight loss intervention. Those who
did not and those with a BMI < 25 kg/m2 received a
lifestyle maintenance intervention. Phase III, lasting a
year, included a randomized controlled trial (RCT)
comparing a more intensive to less intensive weight
loss maintenance intervention for those who lost ≥ 8 lb
in Phase II and a lifestyle maintenance intervention for
the other participants. We did not include a control
group in Phases I and II because we had previously
shown lifestyle and weight loss interventions given
in similar formats to low SES participants were ef-
fective when evaluated in randomized trials [39–42]
and we wanted to offer a lifestyle and weight loss
interventions to as many community members as
possible. Additionally, our CAC strongly encouraged
a study design in which all participants received
“active treatment.”
Participants
The enrollment goal for the lifestyle study was 350
participants; approximately 150 enrolled from the com-
munity and 200 from the high BP study. The rational for
including BP study participants was their increased risk
for CVD and likelihood of benefit from receiving the
lifestyle intervention. To recruit from the community,
the study was publicized through flyers, newspaper arti-
cles, television notices, word of mouth, and the study
website. In an effort to enroll a representative commu-
nity sample, the only inclusion criteria for screening
were age ≥ 18 years and interest in improving diet and
PA behaviors to reduce CVD risk. Screening criteria for
the high BP study were age ≥ 18, established patient at a
participating practice, and a systolic BP ≥ 150 mmHg
when assessed during routine care within the past
12 months. Participants who attended the enrollment
Baseline Measures
Phase I:  Lifestyle Program
6 Month Measures
Phase II:  Participants with BMI kg/m2 offered
weight loss intervention
Weight Loss Program    Maintenance of Lifestyle
12 Month Measures
Phase III:  Participants in weight loss program
offered RCT (randomized controlled trial) of Weight Loss Maintenance; 
others continued with Maintenance of Lifestyle
RCT
Weight Loss 
Maintenance
Maintenance
of Lifestyle
24 Month Measures
Intensive Maintenance Standard Maintenance
Fig. 1 Study overview
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visit for the high BP study were invited to take part
in the lifestyle study until 200 agreed to do so.
Research staff screened potential participants (primar-
ily by phone) to determine if they met the following
additional eligibility criteria: lived in or near Lenoir
County, North Carolina; spoke English; had access to a
telephone; no drug or alcohol abuse within the past two
years; did not have advanced kidney disease or dementia;
did not have psychosis; and did not have a history of
malignancy, other than non-melanoma skin cancer,
unless surgically cured > 5 years ago or in remission. If
so, they were invited to the enrollment visit, conducted
at a central research office or the participants’ clinics. To
identify potential safety issues related to increasing PA, a
modified version of the Physical Activity Readiness
Questionnaire [43] was given. Those who screened posi-
tive or had a myocardial infarction during the preceed-
ing 3 months were required to get approval from their
physician to take part in the PA component of the
intervention.
Lifestyle study intervention
Phase I (months 1–6) diet and PA intervention
The lifestyle study intervention focused on dietary and
PA behaviors and did not address other aspects of life-
style relevant to CVD risk reduction, such as smoking
cessation. The intervention framework was originally de-
veloped by Ammerman and colleagues [44, 45], tested in
a variety of clinical settings in North Carolina [46–48],
and was previously updated to include a greater focus
on carbohydrate quality [39]. To be consistent with the
evolving literature on the importance of high quality fats
in reducing CVD risk [49–56], the intervention was
further revised for this study to include a major focus on
improving fat quality. With this modification, the inter-
vention dietary pattern closely resembled that tested in
the nut intervention arm of the PREDIMED study; thus,
we call it the “Med-South Diet,” given the focus on the
Southeastern US. As shown in Table 1, 9 of the 13 major
recommendations advocated by the PREDIMED inter-
vention diet [20] were almost identical to those in the
Med-South Diet.
The Phase I intervention, described in detail in Section
1a of Additional file 1, included 4 monthly sessions
delivered by a trained counselor. Dietary counseling
comprised about ¾ of intervention content and time;
the rest was devoted to PA counseling, with a goal of
walking ≥ 7,500 steps/day or ≥ 30 min on at least
5 days/week. Participants could choose the intervention
format – either 60-min individual counseling sessions or
120-min group sessions [57, 58] – which were given at a
central research office or the participants’ clinics for those
also enrolled in the high BP study. Spouses and friends
were invited to intervention sessions and for those who
could not attend in person, counseling was offered by tele-
phone. Participants also received an illustrated guide list-
ing local community resources for healthy eating and PA
and a pedometer and activity logs for self-monitoring PA.
At the first counseling session, the lifestyle survey
(Section 1b of Additional file 1) was administered, con-
sisting of the Dietary Risk Assessment (DRA), describe
in detail below and 11 items assessing the amount and
intensity of PA. Then, an overview of the program was
given and the specific dietary content of Session 1 was
reviewed. At the end of the session, the participant and
counselor developed an individually tailored action plan
to help guide the participant’s eating behaviors for the
next month (or until the next counseling session). To do
so, they first reviewed the lifestyle survey page for
Session 1 (Section 1b of Additional file 1, page A-3) and
identified current eating behaviors that “could be im-
proved” or “need to be improved.” Then they reviewed
the dietary tips for these problematic eating behaviors
on the tip sheet for Session 1 (Section 1c of Additional
file 1, page B-24), with tips linked by number and color
coding to the items on the lifestyle survey. Of note, the
tip sheet included recipe suggestions in a “Southern
Style” cookbook given to all participants. Finally, the
counselor and participant identified 2 achievable goals
(participants could opt to choose 1) to work on before
the next visit and documented them on the goal sheet
(Section 1d of Additional file 1, page B-28). If time
permitted during Session 1, PA was also addressed in a
similarly tailored way but with only one goal selected.
Subsequent sessions followed the same format but
opened with a check-in on progress toward goals and
addressed diet and PA.
Phase II (months 7–12)–weight loss and lifestyle
maintenance intervention
Participants with a BMI ≥ 25 kg/m2 could elect to take
part in the weight loss intervention; those who did not
and those with a BMI of < 25 kg/m2 received a lifestyle
maintenance intervention consisting of 3 phone calls, as
previously described [59]. The weight loss intervention
was offered in 2 formats over approximately 16 weeks:
weekly group sessions (16) as previously tested [40, 41, 60],
or 5 group sessions plus 10 phone contacts (combination
intervention) as outlined in Section 2 of Additional file 1.
The major modification from the previously tested weight
loss intervention was the focus on the Med-South dietary
pattern and addition of newer evidence-based behavioral
components (e.g., daily self-weighing) [61].
Phase III (months 13–24)– weight loss and lifestyle
maintenance interventions
Participants losing ≥ 8 lb could elect to take part in the
weight loss maintenance RCT; those who did not and all
Keyserling et al. BMC Public Health  (2016) 16:732 Page 4 of 22
other study participants received brief, quarterly lifestyle
maintenance intervention phone calls. The first 2 calls
addressed diet and PA and, to tailor counseling, began
with the counselor administering a subset of items from
the lifestyle survey. The 3rd and 4th calls were open-
ended, allowing the participant to select a diet or PA
topic for discussion. For the weight loss maintenance
RCT, participants were randomized with a 1:1 allocation
ratio to receive either 36 phone contacts (weekly during
months 1–6 and biweekly during months 7–12), or
18 phone contacts (biweekly during months 1–6, and
monthly during months 7–12) as described in Section
3 of Additional file 1.
High BP study intervention
The HHL high BP study [38] used a community based
participatory research (CBPR) approach in local pri-
mary care practices to design and test a multilevel
intervention with both a practice and patient compo-
nent. The overall goal was to improve BP control rates
and narrow disparities in systolic BP control between
African Americans and Whites and those with lower
and higher health literacy. At the practice level, pro-
viders and staff were engaged during intervention de-
velopment and collaborated with the research team to
design practice quality improvement strategies including:
monthly design team calls, 10 regional dinner meetings to
improve office-based BP management, on-site practice
facilitation to guide practice change, embedding principles
of health literacy in intervention processes and patient
educational materials, and reviewing electronic health
record hypertension performance data.
The patient component included a prospective cohort
study enrolling 525 adults receiving care at these prac-
tices, 200 of whom also took part in the HHL lifestyle
study. At the enrollment visit, participants received a
BP monitor (Omron Model BP 785 or Omron BP 653
wrist monitor), were asked to record BP 3 times weekly,
and received monthly 15-min phone coaching calls for
a year. The coaches used scripted healthy lifestyle and
hypertension management information, motivational
interviewing techniques, and goal setting strategies to
promote behavioral change. Curriculum topics covered:
stress management, alcohol and tobacco use, healthy
eating, PA, patient/provider interaction, medication ad-
herence, and weight loss as previously described [38].
After each phone coaching session, a short session
summary was faxed to the primary care provider. Of
note, the phone coaching component of the high BP
study began almost 6 months after the lifestyle study
intervention such that only 13 participants in the
Table 1 PREDIMED Diet goals20 compared to Med-South Diet goalsa
Food PREDIMED Diet goal Med-South Diet goal
1–Vegetable Oil Olive oil group: ≥ 4
tbsp/day extra virgin olive oil
2–6 servings/day of foods high in healthy fats
(nuts, fish, full fat salad dressings and spreads,
other foods prepared with olive or vegetable
oils, and vegetables with high fat content such
as avocado)
2–Tree nuts and peanuts Nut group: ≥ 3 servings/wkb ≥3 servings/wk
3–Fresh fruits ≥3 servings/day ≥7 servings for fruits and vegetables/day
4–Vegetables ≥3 servings/day
5–Fish (especially fatty fish), seafood ≥3 servings/wk ≥1 servings/wk
6–Legumes ≥3 servings/wk ≥3 servings/wk
7–Sofritob ≥2 servings/wk No recommendation
8–White meat Instead of red meat Consume poultry often
9–Wine with meals (optional,
only for habitual drinkers)
≥7 glasses/wk Do not recommend starting wine consumption,
but provide information on effects of alcohol for
heart health, suggesting up to 1 serving a day
for females and up to 2 for males
10–Soda drinks <1 drink/day <1 drink/day
11–Commercial bakery goods,
sweets, and pastries
<3 servings/wk <3 servings/wk
12–Spread fats <1 serving/day Up to several servings/day of trans fat
free spreads
13–Red and processed meats <1 serving/day ≤1 serving/day
Abbreviations: PREDIMED Prevención con Dieta Mediterránea, tbsp tablespoon, wk week
aRows in italics indicate identical or nearly identical dietary recommendations
bThe PREDIMED intervention recommended nuts daily, but considered nut consumption ≥ 3 servings/wk to be adherent to the nut recommendation
cSofrito is a sauce made with tomato and onion, often including garlic and aromatic herbs, and slowly simmered with olive oil
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lifestyle study received coaching phone calls before the
6 month follow-up visit.
Measures
Outcome measures were assessed at baseline and 6, 12,
and 24 month follow-up visits (except as noted). Previ-
ously validated questionnaires were administered address-
ing overall diet quality (DRA) [44, 62], fruit and vegetable
intake [63], dietary fat quality [64], PA, [65, 66] and quality
of life (SF-12 instrument, Quality Metric, Inc., Lincoln,
RI). The DRA is a 26 item food frequncy questionnaire:
each item contributes a score of 0, 1, or 2, which are
summed for the total score, with range of 0–52. Similarly,
the dietary fat quality questionnaire is comprized of 15
items: 3 about type of margarine are not scored with 12
scored as 0, 1, or 2, summed for a total score ranging from
0 to 24. Weight, as the average of two measures, was
assessed in pounds to the nearest tenth by electronic scale
(Seca 874, Seca, Hanover, MD) and height, measured at
baseline only, was assessed with a portable stadiometer
(Weigh and Measure, LLC, Olney, MD). After being
seated for 5 min, 3 automated BP measurements were
obtained (Omron HEM-907XL, Omron Healthcare, Lake
Forest, IL) at 60 s intervals and averaged. Total and high-
density lipoprotein cholesterol (HDL-C) were assessed at
baseline, 12, and 24 months by enzymatic methods
Phase I:  Lifestyle intervention
Participants (n=291) Method of delivery, N (minutes)
Group Individual Couples Phone
Session 1 (n=291) 115 (118) 156 (59) 18 (82) 2 (44)
Session 2 (n=255) 95 (120) 114 (53) 16 (68) 30 (43)
Session 3 (n=236) 79 (120) 96 (53) 21 (59) 40 (44)
Session 4 (n=227) 89 (120) 88 (53) 15 (59) 35 (44)
Assessed for eligibility (n=642)
- Recruitment from community for lifestyle study only
159 Expressed interest 
2 Not eligible
17 Did not attend enrollment visit
140 Attended enrollment visit
- Recruitment from 5 clinics for both lifestyle and high blood pressure studies
483 Referred from participating practices
7 Unable to contact
476 Contacted
23 Not eligible
24 Not interested
429 Eligible for hypertension study
319 Attended enrollment visit 
226 Chose to participate in lifestyle study
Study sample(n=339)
Lifestyle study enrollment visit (n=366)
27Screen failures
19Did not complete baseline bloodwork
7 Advanced kidney disease
1 Failed to complete screening before cutoff
48 Did not participate in lifestyle intervention
6-month follow-up
251 Assessed
48 Did not show up for visit
40 Withdrawn from study or lost to follow-up: 1 death, 3 medical reasons, 7 moved out of area, 20 requested to stop
participation, 9 lost to follow-up
2 Excluded from analysis: 1 diagnosed with cancer, 1 withdrew from lifestyle study and continued in high blood pressure
study
Fig. 2 Study flow diagram, part 1
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Table 2 Baseline characteristics: overall, by race, and by intervention groupa
Characteristics Overall Raceb Participant selected intervention groupc
African White Lifestyle Weight
loss, group
Weight loss,
combinationAmerican
n = 339 n = 219 n = 117 n = 160 n = 57 n = 81
Demographics
Age, mean (SE) 56 (0.6) 54 (0.8) 58 (1.0) 57 (1.0) 53 (1.3) 55 (1.1)
Female sex 260 (77) 181 (83) 76 (65) 110 (69) 52 (91) 72 (89)
Race
African American 101 (63) 41 (72) 62 (79)
White 58 (37) 16 (28) 17 (21)
Education, y
≤ 8 (middle school or less) 16 (5) 11 (5) 5 (4) 11 (7) 1 (2) 2 (3)
9–11 (some high school) 45 (13) 35 (16) 9 (8) 27 (17) 5 (9) 9 (11)
12 (high school graduate) 128 (38) 94 (43) 34 (29) 60 (37) 20 (35) 33 (41)
13–15 (some college) 79 (23) 45 (21) 33 (28) 35 (22) 15 (26) 18 (22)
16 (college graduate) 49 (14) 26 (12) 22 (19) 17 (11) 11 (19) 13 (16)
> 16 (graduate school) 22 (7) 8 (4) 14 (12) 10 (6) 5 (9) 6 (7)
Education: high school or less 189 (56) 140 (64) 48 (41) 98 (61) 26 (46) 44 (54)
Marital status
Married or living with a partner 159 (47) 82 (37) 76 (65) 69 (43) 23 (40) 41 (51)
Other 180 (53) 137 (63) 41 (35) 91 (57) 34 (60) 40 (49)
Currently have health insurance 251 (74) 156 (71) 92 (79) 117 (73) 45 (79) 58 (72)
Current employment
Working full time 124 (37) 82 (37) 40 (34) 46 (29) 29 (51) 38 (47)
Working part time 42 (12) 31 (14) 10 (8) 23 (14) 4 (7) 10 (12)
Do not work due to health reasons 69 (20) 43 (20) 26 (22) 37 (23) 9 (16) 16 (20)
Retired 53 (16) 26 (12) 27 (23) 29 (18) 7 (12) 8 (10)
Other 51 (15) 37 (17) 14 (12) 25 (16) 8 (14) 9 (11)
Annual household income
< $10,000 62 (20) 50 (26) 11 (10) 40 (29) 6 (11) 9 (11)
$10,000 to < $20,000 64 (21) 45 (23) 19 (17) 29 (21) 11 (21) 18 (23)
$20,000 to < $40,000 84 (28) 60 (31) 23 (21) 32 (24) 14 (26) 27 (35)
$40,000 to < $60,000 33 (11) 15 (8) 18 (17) 11 (8) 8 (15) 9 (11)
$60,000 to < $80,000 27 (9) 13 (7) 14 (13) 11 (8) 11 (21) 5 (6)
≥ $80,000 34 (11) 10 (5) 24 (22) 13 (10) 3 (6) 10 (13)
CVD and risk factors for CVD
Known coronary heart disease 49 (14) 30 (14) 19 (16) 29 (18) 5 (9) 5 (6)
Known CVD 62 (18) 37 (17) 25 (21) 34 (21) 7 (12) 8 (10)
Hypertension 291 (86) 195 (89) 95 (81) 143 (89) 47 (82) 66 (81)
Cholesterol category
High (≥240 mg/dL) 187 (56) 110 (51) 76 (65) 88 (56) 31 (55) 47 (59)
Borderline (200–239 mg/dL) 46 (14) 33 (15) 12 (10) 16 (10) 11 (19) 13 (16)
Desirable (<200 mg/dL) 102 (30) 72 (33) 29 (25) 54 (34) 15 (26) 20 (25)
Diabetes 124 (37) 89 (41) 34 (29) 62 (39) 21 (37) 27 (33)
Current cigarette smoker 54 (16) 37 (17) 17 (14) 36 (22) 4 (7) 5 (6)
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(LabCorp, Burlington, NC). Blood carotenoids (Mo-
lecular Epidemiology and Biomarker Research Labora-
tory, University of Minnesota, Minneapolis, MN) [62]
were assessed at baseline, 6, and 12 months, as previ-
ously described [59]. At each follow-up visit, partici-
pants were queried about adverse events. Participants
received $40 for enrollment, $25 for 6 and 12 month
visits, and $30 for the 24 month visit.
Sample size, randomization, and statistical analysis
The enrollment goal of 350 participants was based on
having a sufficient sample (N = 100) for the embedded
RCT of weight loss maintenance, assuming 60 % of
study participants (N = 210) would choose to be in the
weight loss intervention and 50 % of those (N = 105)
would lose ≥ 8 lb [40]. An N of 100 in the RCT would
provide 80 % power to detect a weight difference of 2 kg
between study groups. In addition, the overall sample of
350 was felt sufficient to describe the primary objective
of the intervention, to improve diet quality at 6 month
follow-up, and the major secondary objectives of improved
diet quality, PA, and weight loss at 12 and 24 month
follow-up.
Study sample characteristics were summarized using
descriptive statistics. Participants who became pregnant,
had bariatric surgery, or were diagnosed with cancer
(excluding non-melanoma skin cancer or localized
breast or prostate cancer diagnosed by screening tests)
were not included in the analysis of outcomes. Other-
wise, pre-post changes in study outcomes were assessed
among returnees, by intervention group, and by race
using paired t-tests for continuous outcomes and
McNemar’s tests for binary outcomes. The carotenoid
index score was log-transformed for obtaining p-values
Table 2 Baseline characteristics: overall, by race, and by intervention groupa (Continued)
Packs of cigarettes smoked per day,
mean (SE) for current smokers
0.7 (0.1) 0.6 (0.1) 0.9 (0.1) 0.7 (0.1) 0.6 (0.2) 0.6 (0.3)
Taking BP lowering medication 260 (77) 176 (80) 83 (71) 129 (81) 43 (75) 60 (74)
Lifestyle mean (SE)
DRA total score 27.8 (0.3) 28.0 (0.5) 27.6 (0.4) 27.8 (0.5) 27.2 (0.7) 27.6 (0.6)
Fat quality screener score 15.5 (0.2) 15.4 (0.2) 15.07 (0.3) 15.4 (0.2) 15.3 (0.3) 15.4 (0.3)
Fruit and vegetable, servings per day 3.4 (0.1) 3.4 (0.1) 3.5 (0.2) 3.5 (0.2) 3.0 (0.3) 3.5 (0.2)
Carotenoid indexe, mean (SE) 40.7 (1.3) 41.9 (1.6) 38.2 (2.5) 41.1 (2.0) 42.1 (3.5) 39.1 (2.4)
Walking time, min/wkf 91 (11.3) 100 (16.2) 73 (11.8) 110 (18.8) 97 (26.5) 55 (13.3)
Activity time, min/wkg 149 (14.0) 150 (18.2) 143 (21.5) 160 (22.7) 148 (29.1) 135 (25.7)
Physiologic mean (SE)
Weight, kg 98.1 (1.4) 100 (1.7) 94 (2.3) 93.8 (2.0) 101.3 (3.3) 106.4 (2.6)
BMI, kg/m2 36 (0.5) 37 (0.6) 34 (0.8) 34 (0.7) 38 (1.1) 40 (1.0)
Systolic BP, mm Hgh 135 (1.2) 136 (1.6) 132 (1.8) 138 (1.8) 130 (2.6) 133 (2.3)
LS study only (n = 139) 125 (1.3) 126 (1.6) 122 (2.2) 124 (2.5) 126 (2.7) 126 (2.0)
LS and HBP study (n = 200) 142 (1.7) 143 (2.2) 139 (2.4) 142 (2.2) 137 (5.2) 142 (4.0)
Diastolic BP, mm Hg 82 (0.7) 83 (0.9) 80 (1.0) 83 (1.0) 82 (1.4) 81 (1.3)
LS study only (n = 139) 79 (0.8) 80 (1.0) 76 (1.4) 77 (1.5) 80 (1.5) 79 (1.5)
LS and HBP study (n = 200) 84 (0.9) 86 (1.3) 83 (1.3) 85 (1.2) 87 (2.7) 84 (2.2)
HbA1c, % of total Hb 6.6 (0.1) 6.7 (0.1) 6.2 (0.1) 6.5 (0.1) 6.9 (0.3) 6.5 (0.2)
Total cholesterol, mg/dL 193 (2.3) 191 (2.8) 196 (4.0) 191 (3.1) 198 (6.0) 189 (4.7)
HDL cholesterol, mg/dL 54 (0.8) 57 (1.0) 50 (1.4) 55 (1.2) 53 (1.8) 53 (1.5)
Abbreviations: BMI body mass index, BP blood pressure, CVD cardiovascular disease, DRA Dietary Risk Assessment, HDL-C high-density lipoprotein, HbA1c
hemoglobin A1c, HBP high blood pressure, LS lifestyle, SE standard error
Note: SI unit conversion factors: To convert all types of cholesterol to millimoles per liter, multiply by 0.0259
a Unless otherwise noted, data are reported as number (percentage) of participants
b 3 categorized as other race
c Participants selected intervention group at 6 month follow-up visit; if they did not attend this visit they were assigned to lifestyle group
d Framingham risk scores calculated as percent chance of developing angina, having a myocardial infarction, or dying of coronary heart disease over a 10 year
time frame
e Carotenoid index, calculated as the sum of α-carotene, β-carotene,β-cryptoxanthin, and zeaxanthin. Data presented are for nonsmokers (n = 261). A higher index
indicates greater fruit and vegetable consumption. Statistical tests performed on log-transformed data
f Includes walking for transportation and exercise
g Includes walking and other moderate and vigorous activity
h Systolic and diastolic blood pressure results are also presented for participants in LS study only and participants in both LS and HBP studies
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Table 3 Change from baseline to 6 monthsa
Outcome Phase 1
Baseline to 6 months
(6 months minus baseline)
n Mean, 95 % CI
Dietary
DRA total score
All 235 4.3 (3.7 to 5.0)***
Subgroup by raceb
–African American 155 4.6 (3.7 to 5.5)***
–White 77 3.9 (2.9 to 5.0)***
Fat quality screener score
All 229 1.4 (1.0 to 1.7)***
–African American 150 1.4 (0.9 to 1.8)***
–White 76 1.3 (0.7 to 2.0)***
Fruit and vegetable servings per day
All 249 0.3 (0.1 to 0.5)**
–African American 168 0.2 (0.0 to 0.5)
–White 78 0.3 (0.0 to 0.7)*
Carotenoid indexc
All 169 −0.9 (−3.3 to 1.5)
–African American 118 −0.2 (−2.8 to 2.5)
–White 49 −3.5 (−8.7 to 1.8)
Physical Activity
Walking time, min/wkd
All 249 64 (19 to 109)**
–African American 168 65 (5 to 125)*
–White 78 66 (4 to 128)*
Activity time, min/wke
All 249 97 (36 to 158)**
–African American 168 106 (28 to 184)**
–White 78 88(−13 to 188)
Blood Pressure Medication
Taking BP lowering medication, %
All 249 2.0 % (−0.3 to 4.4)
–African American 167 1.2 % (−1.7 to 4.1)
–White 78 3.8 % (−0.4 to 8.1)
Physiologic
Systolic BP, mm Hgf
LS study only 119 −4.7 (−6.9 to −2.6)***
LS and HBP study 130 −7.9 (−11.8 to 4.0)***
All 249 −6.4 (−8.7 to −4.1)***
–African American 168 −6.8 (−9.7 to −3.8)***
–White 78 −5.6 (−9.4 to −1.8)**
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from paired t-tests. To explore predictors of change in
BP at follow-up, we used linear regression models that
assessed change in BP associated with change in diet,
PA, and weight, while controlling for selected baseline
characteristics. As the RCT turned out to be substan-
tially under powered (N = 27), weight change for RCT
participants are described, but statistical tests compar-
ing outcomes by group were not performed. SAS
version 9.3 (SAS Institute, Cary, NC) was used for ana-
lyses, with p ≤ .05 considered statistically significant.
Results
Enrollment and baseline characteristics of participants
As depicted in Fig. 2, 339 participants completed base-
line measures and comprised the study sample, with
baseline characteristics presented in Table 2. The mean
age was 56 years (range 18 to 92), 260 (77 %) were
female, 219 (65 %) were African American, 124 (37 %)
were employed full-time, 251 (74 %) had health insur-
ance, 210 (62 %) had an annual household income
of ≤ $40,000 per year, 291 (86 %) had hypertension,
and the mean BMI was 36 kg/m2. As anticipated, the
mean baseline blood pressure was substantially higher
in participants taking part in both the lifestyle and
high BP study as compared to those only taking part
in the lifestyle study. On average, African American
participants were younger, less educated, had lower
household income, and with the exception of HDL-C
had more CVD risk factors.
Phase I outcomes
As outlined in Fig. 2, 291 (86 %) participants attended
the first intervention visit, with 115 (40 %) choosing
group format, and the rest individual counseling. Over-
all, 237 (70 %) completed all counseling sessions. As
shown in Table 3, from baseline to 6 month follow-up,
there were improvements in self-reported measures of
diet quality (higher score indicates improved diet qual-
ity): DRA score increased 4.4 units (95 % CI 3.7 to 5.0),
fat quality score increased 1.4 units (1.0 to 1.7), and
servings of fruit and vegetables per day increased by 0.3
(0.1 to 0.5). In addition, there were increases in walking
of 64 min/week (19 to 110) and total activity time (walk-
ing plus other types of moderate to vigorous PA) of
97 min/week (36 to 158). For physiologic outcomes,
change in systolic BP was −6.4 mmHg (−8.7 to −4.1),
diastolic BP −3.7 mmHg (−4.9 to −2.5), and weight
−0.7 kg (−1.2 to −0.3). Of note, there were significant
reductions in systolic, −4.7 mmHg (−6.9 to −2.6) and
diastolic, −2.8 mmHg (−4.2 to −1.3) BP in the lifestyle
only group. Among those who took part in both the life-
style and high BP studies the systolic, −7.9 mmHg
(−11.8 to 4.0), and diastolic, −4.6 mmHg (−6.5 to −2.7),
BP reductions were larger. In addition, desirable out-
comes were similar or larger for African Americans
compared to whites.
Of 242 participants completing the Phase I acceptability
questionnaire, 170 (70 %) strongly agreed and 66 (27 %)
agreed with the following statement: “I would recommend
Table 3 Change from baseline to 6 monthsa (Continued)
Diastolic BP, mm Hg
LS study only 119 −2.8 (−4.2 to −1.3)***
LS and HBP study 130 −4.6 (−6.5 to −2.7)***
All 249 −3.7 (−4.9 to −2.5)***
–African American 168 −3.5 (−5.1 to −2.0)***
–White 78 −4 (−6.1 to −2.3)***
Weight, kg
All 248 −0.7 (−1.2 to −0.3)**
-African American 167 −0.8 (−1.4 to −0.3)**
–White 78 −0.4 (−1.3 to 0.5)
Weight, ≥ 5 % weight loss, %
All 248 9 % (6 to 13)
–African American 167 12 % (7 to 17)
–White 78 4 % (0 to 8)
Abbreviations: BP blood pressure, CI confidence interval, DRA dietary risk assessment, HBP high blood pressure, LS lifestyle
Note: Boldface indicates statistical significance *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001
a Data are means except where noted
b 3 categorized as other race
c Carotenoid index, calculated as the sum of α-carotene, β-carotene,β-cryptoxanthin, and zeaxanthin. Data presented are for nonsmokers and available only
through 12 month follow-up visit. A higher index indicates greater fruit and vegetable consumption. Statistical tests performed on log-transformed data
d Includes walking for transportation and exercise
e Includes walking and other moderate and vigorous activity
f Systolic and diastolic blood pressure results are also presented for participants in LS study only and participants in both LS and HBP studies
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the program to others.” Similarly, 138 (57 %) strongly
agreed and 99 (41 %) agreed that “the information pro-
vided was easy to understand.” In terms of diet counseling
content, the information on nuts, spreads, dressings and
oils was considered most helpful with 185 (76 %) indicat-
ing this session was very helpful and 43 (18 %) somewhat
helpful.
Phase II outcomes
Figure 3 shows 298 (88 %) participants continued into
Phase II: of these, 57 chose the group-based weight loss
and 81 the combination format, with 160 receiving the
lifestyle maintenance intervention (of these, 111
attended the 6 month measurement visit and 93 (84 %)
had BMI ≥ 25 kg/m2 but did not choose to be in the
weight loss program). Change in outcomes from 6 to 12
and baseline to 12 months are shown in Tables 4 and 5.
Self-reported dietary changes were generally maintained
through 12 months, but more so for the weight loss
groups, especially for fruit and vegetable intake. From 6
to 12 months, the carotenoid index increased signifi-
cantly for whites and from baseline to 12 months, there
was a statistically significant increase in the carotenoid
index score for all participants. The increase in PA re-
ported from baseline to 6 months was generally main-
tained at 12 months, though less so for the group-based
weight loss participants. Change in BP from baseline to
12 months among participants in the lifestyle only
study was: systolic, −1.4 mmHg (−4.5 to 1.6); diastolic
−2.0 mmHg (−3.7 to −0.4). For those in both studies, it
Fig. 3 Study flow diagram, part 2
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Table 4 Change in dietary and physical activity outcomes at 12 monthsa
Outcome Phase 2
6 months to 12 months Baseline to 12 months
(12 months minus 6 months) (12 months minus baseline)
n Mean, 95 % CI n Mean, 95 % CI
Dietary
DRA total score
All 219 −0.7 (−1.3 to −0.1)* 227 3.3 (2.5 to 4.0)***
Subgroup by raceb
–African American 151 −0.2 (−1.0 to 0.6) 156 4.0 (3.1 to 4.9)***
–White 66 −1.9 (−2.7 to −1.1)*** 69 1.7 (0.4 to 3.0)**
Subgroup by interventionc
–Lifestyle 93 0.0 (−1.0 to 0.9) 102 1.7 (0.7 to 2.8)***
–Wt loss, group 51 −0.3 (−1.5 to 0.9) 51 5.1 (3.8 to 6.4)***
–Wt loss, combination 75 −1.7 (−2.8 to −0.7)*** 74 4.1 (2.7 to 5.6)***
Fat quality screener score
All 218 −0.1 (−0.5 to 0.2) 225 1.0 (06 to 1.3)***
–African American 150 0.1 (−0.3 to 0.5) 154 1.2 (0.8 to 1.7)***
–White 66 −0.6 (−1.2 to −0.1)* 69 0.4 (−0.2 to 1.0)
–Lifestyle 93 0.2 (−0.4 to 0.8) 102 0.7 (0.1 to 1.2)*
–Wt loss, group 51 −0.1 (−0.8 to 0.5) 48 1.3 (0.6 to 2.0)***
–Wt loss, combination 74 −0.6 (−1.1 to −0.1)* 75 1.2 (0.6 to 1.8)***
Fruit and vegetable servings per day
All 221 0.4 (0.2 to 0.5)*** 253 0.5 (0.3 to 0.8)***
–African American 153 0.5 (0.2 to 0.7)*** 178 0.5 (0.2 to 0.9)**
–White 66 0.0 (−0.3 to 0.3) 73 0.5 (0.1 to 0.9)**
–Lifestyle 95 0.1 (−0.2 to 0.4) 127 0.1 (−0.2 to 0.5)
–Wt loss, group 51 0.5 (0.1 to 0.9)* 51 1.0 (0.5 to 1.5)***
–Wt loss, combination 75 0.6 (0.2 to 0.9)*** 75 0.9 (0.4 to 1.3)***
Carotenoid indexd
All 105 3.7 (0.4 to 6.9) 117 3.1 (−0.4 to 6.7)*
–African American 77 3.1 (−0.8 to 7.1) 88 3.0 (−1.4 to 7.5)
–White 27 5.6 (−0.4 to 11.7)* 28 3.4 (−2.0 to 8.9)
–Lifestyle 33 5.6 (−0.2 to 11.9) 40 3.1 (−3.2 to 9.5)
–Wt loss, group 29 1.9 (−3.5 to 7.3) 31 3.7 (−3.0 to 10.4)
–Wt loss, combination 43 3.2 (−2.0 to 8.4) 46 2.7 (−2.9 to 8.3)
Physical Activity
Walking time, min/wke
All 221 7 (−49 to 63) 253 71 (28 to 113)***
–African American 153 16 ((−59 to 91) 178 68 (13 to 123)*
–White 66 −14 (−88 to 61) 73 82 (23 to 142)**
–Lifestyle 95 29 (−56 to 113) 127 60 (−10 to 130)
–Wt loss, group 51 −21 (−164 to 123) 51 66 (−27 to 158)
–Wt loss, combination 75 −2 (−81 to 77) 75 93 (45 to 141)***
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was: systolic, −9.3 mmHg (−13.6 to −5.1); diastolic
−7.0 mmHg (−9.0 to −4.9). At 12 months, among all
participants there was a significant change in HDL-C of
−2 mg/dL (−2.8 to −0.4) and a non-significant change
in total cholesterol of −3 mg/dL (−7.0 to 0.7).
From baseline to 12 months, weight change was −0.9 kg
(−2.1 to 0.2) for the lifestyle maintenance intervention,
with 24 (19 %) losing ≥ 5 % body weight; −3.1 kg (−4.9 to
−1.3) for the group-based weight loss intervention, with
17 (34 %) losing ≥ 5 % body weight; and −2.1 kg (−3.2 to
−1.0) for the combination weight loss intervention, with
17 (23 %) ≥ 5 % body weight. During Phase II, outcomes
were similar for African Americans and Whites. At the
completion of Phase II, 46 participants in the group-based
and 70 in the combination weight loss intervention com-
pleted an acceptability survey. Among group participants,
37 (80 %) reported they were very satisfied and 6 (13 %)
reported they were satisfied with the intervention. For
combination participants, 51 (71 %) reported they were
very satisfied and 12 (17 %) reported they were satisfied
with the intervention.
Phase III outcomes
Of the 30 participants who lost ≥ 8 lb at 12 month
follow-up, 27 (90 %) agreed to take part in the mainten-
ance of weight loss RCT, while 258 received the lifestyle
maintenance intervention (Fig. 3). Among those in the
RCT, compared to baseline, weight change was −7.0 kg
at 12 and −5.9 kg at 24 months for the 15 participants in
the intensive intervention and −6.9 kg and −2.4 kg, re-
spectively for the 12 participants in the less intensive
intervention. Those losing ≥ 5 % body weight at 24 months
included 7 (47 %) receiving the more intensive and 3
(25 %) receiving the less intensive intervention.
Change in outcomes from 12 to 24 and baseline to
24 months for all returnees are shown in Tables 6 and 7.
In general, during the 2nd year of the intervention, there
was minor attenuation in self-reported dietary behaviors
and more pronounced attenuation of PA. Change in BP
from baseline to 24 months among participants in the life-
style only study was: systolic, −4.2 (−7.3 to 1.2); diastolic
−5.2 (−7.1 to −3.3). For those in both studies, it was:
systolic, −9.4 (−13.4 to −5.4); diastolic −7.8 (−10.1 to
−5.5). Compared to baseline, weight change was −1.7 kg
(−2.9 to −0.5) for the lifestyle only intervention with 29
(23 %) losing ≥ 5 % body weight, −2.1 kg (−4.3 to 0.0) for
the group weight loss intervention with 13 (25 %) losing ≥
5 % body weight, and −1.1 kg (−2.7 to 0.4) for the combin-
ation weight loss intervention with 15 (21 %) ≥ 5 % body
weight. During Phase III, outcomes were similar for Afri-
can Americans and Whites. Change in blood lipids at
24 month was minimal.
Predictors of BP change, quality of life, and adverse
events
At all follow-up time points, we examined the associ-
ation between change in BP as a function of change in
diet, PA, or weight, controlling for the baseline value of
BP and baseline assessment of age, sex, race, educational
achievement, diabetes status, and weight. In our model
for change in diastolic BP at 24 month follow-up, weight
loss was significantly associated with a reduction in dia-
stolic BP (p = 0.03) for all participants and for those in
both studies (p = 0.02). There were no other significant
associations. At 6 and 12 month follow-up, quality of life
measures were generally improved, but not significantly.
At 24 month follow-up, compared to baseline there was
statistically significant improvement in the mental
Table 4 Change in dietary and physical activity outcomes at 12 monthsa (Continued)
Activity time, min/wkf
All 221 −26 (−96 to 44) 253 83 (30 to 136)**
–African American 153 −19 (−115 to 77) 178 75 (14 to 136)*
–White 66 −42 (−115 to 32) 73 110 (2 to 218)*
–Lifestyle 95 3 (−84 to 90) 127 67 (−24 to 158)
–Wt loss, group 51 −90 (−310 to 131) 51 108 (9 to 208)*
–Wt loss, combination 75 −19 (−105 to 66) 75 93 (35 to 151)**
Abbreviations: BP blood pressure, CI confidence interval, DRA dietary risk assessment
Note: Boldface indicates statistical significance *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001
a Data are means except where noted
b 3 categorized as other race
c Participants selected intervention group at 6 month follow-up visit; if they did not attend this visit they were assigned to lifestyle group
d Carotenoid index, calculated as the sum of α-carotene, β-carotene,β-cryptoxanthin, and zeaxanthin. Data presented are for nonsmokers and available only
through 12 month follow-up visit. A higher index indicates greater fruit and vegetable consumption. Statistical tests performed on log-transformed data
e Includes walking for transportation and exercise
f Includes walking and other moderate and vigorous activity
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Table 5 Change in blood pressure medication and physiologic outcomes at 12 monthsa
Outcome Phase 2
6 months to 12 months Baseline to 12 months
(12 months minus 6 months) (12 months minus baseline)
n Mean, 95 % CI n Mean, 95 % CI
Blood Pressure Medication
Taking BP lowering medication, %
All 221 −0.5 % (−2.8 to 1.9) 253 0.0 % (−3.3 to 3.3)
–African American 153 0.0 % (−3.1 to 3.1) 178 −0.6 % (−4.5 to 3.4)
–White 66 −1.5 % (−4.5 to 1.4) 73 1.4 % (−4.6 to 7.4)
–Lifestyle 95 −1.0 % (−3.1 to 1.0) 127 −0.8 % (−5.4 to 3.8)
–Wt loss, group 51 −2.0 % (−8.6 to 4.7) 51 −2.0 % (−10.5 to 6.6)
–Wt loss, combination 75 1.3 % (−3.2 to 5.8) 75 2.7 % (−2.5 to 7.9)
Physiologic
Systolic BP, mm Hg
LS study only 99 3.2 (0.3 to 6.2)* 101 −1.4 (−4.5 to 1.6)
LS and HBP study 121 −2.5 (−6.5 to 1.4) 150 −9.3 (−13.6 to −5.1)***
All 220 0.0 (−2.5 to 2.6) 251 −6.1 (−9.0 to −3.3)***
Subgroup by raceb
–African American 152 −0.9 (−4.0 to 2.1) 176 −6.9 (−10.5 to −3.3)***
–White 66 2.5 (−2.5 to 7.4) 73 −4.2 (−8.8 to 0.3)
Subgroup by interventionc
–Lifestyle 95 −2.2 (−6.2 to 1.8) 126 −8.3 (−12.6 to −3.9)***
–Wt loss, group 50 3.3 (−1.0 to 7.6) 50 −3.6 (−7.8 to 0.5)
–Wt loss, combination 75 0.7 (−3.8 to 5.3) 75 −4.3 (−9.7 to 1.1)
Diastolic BP, mm Hg
LS study only 99 0.4 (−1.4 to 2.2) 101 −2.0 (−3.7 to −0.4)*
LS and HBP study 121 −3.1 (−5.3 to −1.0)** 150 −7.0 (−9.0 to −4.9)***
All 220 −1.5 (−2.9 to −0.1)* 251 −5.0 (−6.4 to −3.6)***
–African American 152 −2.3 (−4.0 to −0.5)** 176 −5.2 (−7.0 to −3.4)***
–White 66 0.7 (−1.8 to 3.2) 73 −4.2 (−6.4 to −1.9)***
–Lifestyle 95 −2.2 (−4.4 to 0.1) 126 −5.4 (−7.5 to −3.2)***
–Wt loss, group 50 1.2 (−1.0 to 3.4) 50 −4.2 (−6.9 to −1.6)**
–Wt loss, combination 75 −2.5 (−5.1 to 0.1) 75 −4.5 (−7.2 to −2.3)***
Weight, kg
All 219 −1.1 (−1.7 to −0.5)*** 250 −1.7 (−2.5 to 1.0)***
–African American 151 −0.9 (−1.6 to −0.3)** 175 −1.7 (−2.6 to −0.8)***
–White 66 −1.4 (−2.3 to −0.3)* 73 −1.6 (−3.1 to −0.2)*
–Lifestyle 94 −0.3 (−1.3 to 0.6) 125 −0.9 (−2.1 to 0.2)
–Wt loss, group 50 −1.3 (−2.4 to −0.2)* 50 −3.1 (−4.9 to −1.3)***
–Wt loss, combination 75 −1.9 (−2.8 to −1.0)*** 75 −2.1 (−3.2 to −1.0)***
Weight, ≥ 5 % weight loss, %
All 219 18 % (13 to 23) 250 23 % (18 to 28)
–African American 151 18 % (12 to 24) 175 23 % (17 to 30)
–White 66 18 % (9 to 28) 73 22 % (12 to 31)
–Lifestyle 94 14 % (7 to 21) 125 19 % (12 to 26)
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composite score for all participants and for the lifestyle
subgroup (p < .05). There were no adverse events attrib-
uted to the intervention; however, 23 participants had at
least one adverse CVD event during follow-up, includ-
ing: 3 acute myocardial infarctions (1 death), 5 hospital
evaluations for angina, 1 coronary artery bypass surgery,
6 episodes of heart failure, 3 hospital evaluations for
hypertension, 2 strokes, and 3 others.
Discussion
In this study to evaluate a diet, PA, and weight loss
intervention that promoted a Mediterranean style eating
pattern adapted for the southeastern US, participants
reported substantial improvements in dietary behaviors
(improved consumption of high quality fats and fruit
and vegetables) at 6 month follow-up that were generally
maintained through 24 months, with increases in self-
reported fruit and vegetable consumption corroborated
by the objective measure of blood carotenoids at 12 month
follow-up. A major difference between the diet pattern
tested in this study and most previous dietary intervention
trials conducted in the US, including several we have
conducted in low-income populations [39, 45–48, 67, 68]
was the recommendation to increase consumption of
foods containing high quality fats (no restriction on total
fat intake), with a focus on increasing fat intake from
nuts and vegetable oils. We believe this recommenda-
tion to consume more healthful fats was well received
because we encouraged consumption of many foods
that historically have been an important part of the
southern diet, but previously discouraged by dietary
guidelines focusing on fat restriction. Perhaps this
appealing aspect of the Med-South Diet contributed
to the maintenance of dietary change through
24 months.
A major goal of this project was to develop an inter-
vention that would be similarly effective among minority
and non-minority participants, in hopes that such an
intervention may decrease health disparities. Overall,
both lifestyle and physiologic outcomes were similar by
race. Moreover, for systolic BP, there were trends towards
a greater reduction among African American participants.
Relevant to our findings on BP change, in a sub-study
of the PREDIMED randomized trial, Estruch [22] exam-
ined the effect on BP of a Mediterranean diet supple-
mented with extra virgin olive oil (n = 257) and nuts
(n = 257) compared to a low-fat diet (n = 256). At
3 month follow-up, systolic BP was reduced by
4.8 mmHg in the olive oil group and 6.5 mmHg in
the nuts group, with 0.64 mmHg increase in the low-
fat group. In our study, among participants in the
lifestyle only group, we observed a similar reduction
Table 5 Change in blood pressure medication and physiologic outcomes at 12 monthsa (Continued)
–Wt loss, group 50 22 % (10 to 34 50 34 % (21 to 47)
–Wt loss, combination 75 21 % (12 to 31) 75 23 % (13 to 32)
Total cholesterol, mg/dLd
All 221 −3 (−7.0 to 0.7)
–African American 155 −4 (−8.5 to 0.4)
–White 64 0 (−7.8 to 7.7)
–Lifestyle 106 −3 (−9.1 to 2.7)
–Wt loss, group 44 −6 (−13.5 to 1.4)
–Wt loss, combination 71 −1 (−8.0 to 5.2)
HDL cholesterol, mg/dL
All 220 −2 (−2.8 to −0.4)**
–African American 154 −2 (−3.0 to 0)*
–White 64 −2 (−3.8 to 0.3)
–Lifestyle 106 −2 (−3.8 to −0.1)
–Wt loss, group 44 −1 (−3.1 to 1.5)
–Wt loss, combination 70 −1 (−3.5 to 0.5)
Abbreviations: BP blood pressure, CI confidence interval, HBP high blood pressure, LS lifestyle
Note: Boldface indicates statistical significance *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001.
SI unit conversion factors: To convert all types of cholesterol to millimoles per liter, multiply by 0.0259
a Data are means except where noted
b 3 categorized as other race
c Participants selected intervention group at 6 month follow-up visit; if they did not attend this visit they were assigned to lifestyle group
d To convert from mg/dL to mmol/L divide by 68.37
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Table 6 Change in dietary and physical activity outcomes at 24 monthsa
Outcome Phase 3
12 months to 24 months Baseline to 24 months
(24 months minus 12 months) (24 months minus baseline)
n Mean, 95 % CI n Mean, 95 % CI
Dietary
DRA total score
All 236 −0.3 (−0.8 to 0.2) 226 2.9 (2.3 to 3.6)***
Subgroup by raceb
–African American 168 −0.7 (−1.3 to 0.0)* 158 3.0 (2.2 to 3.8)***
–White 66 0.6 (−0.2 to 1.4) 66 2.8 (1.6 to 4.0)***
Subgroup by interventionc
–Lifestyle 116 −0.1 (−0.8 to 0.6) 105 1.8 (0.9 to 2.7)***
–Wt loss, group 48 −1.1 (−2.1 to −0.2)* 50 4.0 (2.7 to 5.4)***
–Wt loss, combination 72 0.0 (−0.9 to 1.0) 71 3.9 (2.6 to 5.2)***
Fat quality screener score
All 236 −0.4 (−0.7 to 0)* 224 0.7 (0.3 to 1.0)***
–African American 168 −0.6 (−1.0 to −0.1)** 156 0.7 (0.2 to 1.1)**
–White 66 0.1 (−0.5 to 0.6) 66 0.6 (−0.2 to 1.5)
–Lifestyle 116 −0.7 (−1.3 to −0.2)** 105 0.1 (−0.5 to 0.7)
–Wt loss, group 48 −0.2 (−0.9 to 0.5) 47 1.2 (0.4 to 2.0)**
–Wt loss, combination 72 0.1 (−0.5 to 0.6) 72 1.1 (0.5 to 1.7)***
Fruit and vegetable servings per day
All 237 −0.2 (−0.4 to 0.1) 250 0.4 (0.2 to 0.6)***
–African American 169 −0.2 (−0.5 to 0.1) 177 0.3 (0.1 to 0.6)*
–White 66 0.0 (−0.4 to 0.3) 71 0.5 (0.1 to 0.8)**
–Lifestyle 117 0.1 (−0.2 to 0.4) 127 0.2 (−0.1 to 0.5)
–Wt loss, group 48 −0.1 (−0.6 to 0.3) 51 0.9 (0.4 to 1.4)***
–Wt loss, combination 72 −0.5 (−0.9 to −0.1)** 72 0.3 (−0.1 to 0.8)
Physical Activity
Walking time, min/wkd
All 237 −52 (−89 to −15)** 250 22 (−13 to 56)
–African American 169 −49 (−95 to −3)* 177 21 (−25 to 67)
–White 66 −63 (−123 to −2)* 71 27 (−12 to 65)
–Lifestyle 117 −55 (−111 to 2) 127 8 (−50 to 65)
–Wt loss, group 48 −81 (−163 to 0)* 51 −4 (−69 to 60)
–Wt loss, combination 72 −29 (−84 to 27) 72 65 (22 to 108)**
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in systolic BP at 6 and 24 month follow-up, with a
smaller reduction at 12 months. Among those taking
part in both the lifestyle and high BP studies, the re-
duction in systolic BP was larger at all follow-up time
up, likely due to the combined effect of diet and PA
change and improved medication adherence. With
regard to blood lipid change, in the PREDIMED sub-
study, total cholesterol was reduced by 3.9 mg/dL in
the olive oil group and 5.0 mg/dL in the nuts group,
while increasing 0.74 mg/dL in the low-fat group. In
our study, total cholesterol was reduced 3 mg/dL at
12 and 24 month follow-up. However, in the PRE-
DIMED study, HDL-C increased 2.4 and 0.9 mg/dL
in the olive oil and nut groups respectively, while decreas-
ing 0.4 mg/dL in the low-fat group. Despite improved self-
reported diet and PA behaviors and modest weight loss, in
our study, HDL-C was reduced by 2 and 1 mg/dL, re-
spectively at 12 and 24 month follow-up.
Of the 249 participants taking part in Phase II that
returned for 6 month follow-up weights, 231 (93 %) had
a BMI > 25 kg/m2 and were eligible for the weight loss
intervention. It is noteworthy that 138 (60 %) elected to
receive the weight loss intervention, suggesting a high
level of interest in weight loss among overweight study
participants. Though a sub-set of weight loss partici-
pants achieved and maintained meaningful weight loss;
overall, the weight loss component of this trial did not
achieve study goals. First, we expected 60 % of partici-
pants to take part in the weight loss program, but only
138 (40 % of enrollees and 55 % of those returning and
eligible at 6 month follow-up) elected to do so. Second,
for weight loss participants, the average weight loss at
the conclusion of the weight loss intervention (baseline
to 12 months) of 2.5 kg was less than observed in our
previous weight loss intervention trials [40, 41]. Because
fewer participants elected to take part in the weight loss
intervention and weight loss was less than expected, the
embedded RCT of weight loss maintenance was substan-
tially underpowered. Possible reasons for less weight loss
than expected include the non-selected sample (in our
prior weight loss studies, participants were screened for
motivation to lose weight) and an older population with
more co-morbidities. An unexpected positive finding
was that 20 % of African American participants who
returned for follow-up at the conclusion of Phase I,
which was not a weight loss intervention, lost ≥ 5 % of
body weight.
Though the US Preventive Services Task Force [69]
recommends clinicians should offer and refer all adults
with BMI ≥ 30 kg/m2 to an intensive weight loss pro-
gram, most published weight loss studies conducted in
primary care and community settings [70–72] have in-
cluded selected samples, often younger, with lower BMI,
and with less co-morbidities than those seen in routine
practice. In contrast, we offered our weight loss inter-
vention to a non-selected, high risk, older, and largely
minority sample. With the caveat that our weight
change was compared to baseline and not a control
group, our achieved weight loss, though modest, was
greater than reported in a recent meta-analysis by
Booth [70] assessing behavioral weight loss programs
in primary care settings with pooled results across 15
RCTs of −1.4 kg (−2.1 to −0.6). Furthermore, in a re-
cent review [31] of weight loss studies conducted in
disadvantaged populations, only 20 % lost more than
5 % of body weight at follow-up, which is less than
we achieved in this study. However, overall weight
loss was modest, especially at 24 month follow-up,
highlighting the need for more effective weight loss
interventions for high risk populations, as enrolled in
this study.
This study has several limitations. The overall design
(excluding the embedded RCT) was a pre-post compari-
son study with no control group. Thus, observed
Table 6 Change in dietary and physical activity outcomes at 24 monthsa (Continued)
Activity time, min/wke
All 237 −40 (−91 to 11) 250 48 (−7 to 103)
–African American 169 −25 (−89 to 40) 177 54 (−17 to 124)
–White 66 −82 (−164 to −0.5)* 71 39 (−46 to 124)
–Lifestyle 117 −17 (−106 to 73) 127 51 (−46 to 149)
–Wt loss, group 48 −116 (−208 to −24)** 51 12 (−70 to 95)
–Wt loss, combination 72 −27 (−84 to 29) 72 68 (7 to 129)*
Abbreviations: BP blood pressure, CI confidence interval, DRA dietary risk assessment
Note: Boldface indicates statistical significance *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001
a Data are means except where noted
b 3 categorized as other race
c Participants selected intervention group at 6 month follow-up visit; if they did not attend this visit they were assigned to lifestyle group
d Includes walking for transportation and exercise
e Includes walking and other moderate and vigorous activity
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Table 7 Change in blood pressure medication and physiologic outcomes at 24 monthsa
Outcome Phase 3
12 months to 24 months Baseline to 24 months
(24 months minus 12 months) (24 months minus baseline)
n Mean, 95 % CI n Mean, 95 % CI
Blood Pressure Medication
Taking BP lowering medication, %
All 237 0.4 % (−2.3 to 3.2) 250 0.8 % (−3.0 to 4.6)
–African American 169 1.2 %(−1.6 to 4.0) 177 1.1 % (−3.3 to 5.6)
–White 66 0.0 % (−5.9 to 5.9) 71 1.4 % (−5.9 to 8.7)
–Lifestyle 117 2.6 % (−1.1 to 6.3) 127 1.6 % (−4.2 to 7.3)
–Wt loss, group 48 2.1 % (−5.0 to 9.1) 51 2.0 % (−6.6 to 10.5)
–Wt loss, combination 72 −4.2 % (−8.8 to 0.4) 72 −1.4 % (−7.5 to 4.7)
Physiologic
Systolic BP, mm Hg
LS study only 95 −2.8 (−6.4 to 0.7) 104 −4.2 (−7.3 to 1.2)**
LS and HBP study 140 −0.2 (−3.8 to 3.5) 146 −9.4 (−13.4 to −5.4)***
All 235 −1.3 (−3.9 to 1.3) 250 −7.2 (−9.9 to −4.6)***
Subgroup by raceb
–African American 167 −2.0 (−5.3 to 1.2) 177 −8.4 (−11.8 to −5.1)***
–White 66 0.9 (−3.3 to 5.2) 71 −4.1 (−8.5 to 0.4)
Subgroup by interventionc
–Lifestyle 116 −1.2 (−4.9 to 2.5) 127 −8.8 (−12.9 to −4.8)***
–Wt loss, group 47 0.4 (−3.9 to 4.8) 51 −3.9 (−8.4 to 0.6)
–Wt loss, combination 72 −2.4 (−7.8 to 2.9) 72 −6.8 (−11.8 to −1.9)**
Diastolic BP, mm Hg
LS study only 95 −3.4 (−5.4 to −1.5)*** 104 −5.2 (−7.1 to −3.3)***
LS and HBP study 140 −0.9 (−2.9 to 1.0) 146 −7.8 (−10.1 to −5.5)***
All 235 −1.9 (−3.4 to −0.5) 250 −6.7 (−8.3 to −5.1)***
–African American 167 −2.4 (−4.2 to 0.5)** 177 −7.2 (−9.2 to −5.1)***
–White 66 −1.0 (−3.0 to 1.0) 71 −5.4 (−7.6 to −3.3)***
–Lifestyle 116 −1.9 (−4.0 to 0.2) 127 −6.8 (−9.1 to −4.4)***
–Wt loss, group 47 −3.1 (−5.8 to −0.4)* 51 −7.7 (−10.7 to −4.6)***
–Wt loss, combination 72 −1.3 (−3.9 to 1.3) 72 −6.0 (−8.8 to −3.2)***
Weight, kg
All 232 0.1 (−0.6 to 0.8) 247 −1.6 (−2.5 to −0.7)***
–African American 164 −0.1 (−1.0 to .08) 174 −1.8 (−2.8 to −0.8)***
–White 66 0.6 (−0.6 to 1.7) 71 −1.0 (−2.9 to 0.8)
–Lifestyle 113 −0.9 (−2.0 to 0.1) 124 −1.7 (−2.9 to −0.5)**
–Wt loss, group 47 1.2 (−0.4 to 2.8) 51 −2.1 (−4.3 to 0.0)*
–Wt loss, combination 72 1.0 (−0.2 to 2.2) 72 −1.1 (−2.7 to 0.4)
Weight, ≥ 5 % weight loss, %
All 232 12 % (8 to 16) 247 23 % (18 to 28)
–African American 164 12 % (7 to 17) 174 24 % (18 to 31)
–White 66 12 % (4 to 20) 71 18 % (9 to 27)
–Lifestyle 113 16 % (9 to 23) 124 23 % (16 to 31)
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changes could be due to secular trends or other factors.
With regard to secular trends, data on overweight and
obesity from the behavioral risk factor surveillance sys-
tem (BRFSS) for all of North Carolina and for Eastern
North Carolina [73] suggest no reduction in weight for
the adult population from 2011 to 2014 (see Additional
file 2: Table S1). During this same time period, BRFSS
data for both North Carolina and eastern North Carolina
adults, suggest a slight increase in PA from 2011 to 2014
(see Additional file 3: Table S2). Many outcomes were
self-reported, which may be exaggerated due to social
desirability reporting bias. Also, we present many
comparisons and some p-values may be significant
by chance. Further, our sample size was relatively
small for some of the subgroup outcomes reported.
Finally, the generalizability of our findings may be
limited to samples similar to those enrolled in this
study.
Conclusions
In this study promoting a Mediterranean style dietary
pattern as a major component of a lifestyle and weight
loss intervention to reduce CVD risk, the large majority
of participants reported substantial improvement in diet-
ary intake and a meaningful percentage lost weight and
maintained weight loss. Importantly, as lifestyle and
physiologic changes were similar for African American
and white participants, this type of culturally tailored
intervention has the potential to reduce both CVD risk
and disparities in CVD rates. Future research should
include RCTs enrolling similar high risk populations that
assess change in CVD risk factors and ultimately change
in CVD events.
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